Relief for Mediheal as Parliament Recommends Lifting Sanctions Amid Ongoing Transplant Probe

 Mediheal Group of Hospitals is poised to resume most of its medical services after the National Assembly Health Committee recommended the lifting of sanctions previously imposed on the institution and its affiliates. However, restrictions on organ transplant licenses will remain in place pending further regulatory review.

The committee’s recommendation offers a significant reprieve to Mediheal’s founder, former Kesses MP Dr. Swarup Mishra, who has repeatedly denied allegations linking the hospital to an international organ trafficking network. The claims emerged following investigative reports by foreign media outlets, which alleged Kenya’s involvement in a broader global syndicate.

Alongside Mediheal Group, the committee also proposed lifting sanctions on St. Luke’s Orthopaedic and Trauma Hospital and Oak Tree Centre for Kidney and Chronic Disease. The facilities had faced operational restrictions after the allegations triggered scrutiny from health authorities and regulatory agencies.

Despite the easing of sanctions, transplant-related services will remain suspended. Lawmakers emphasized the need for continued oversight and regulatory clarity before reinstating such specialized procedures, citing the seriousness of the accusations and the potential risks involved.

“The committee’s decision reflects a balance between ensuring continued access to essential healthcare services and maintaining strict vigilance over sensitive medical practices,” a source familiar with the proceedings noted.

For Dr. Mishra, the development marks a turning point in a controversy that has cast a shadow over both his professional and political standing, particularly in Eldoret, where Mediheal serves as a key healthcare provider. While the lifting of sanctions is expected to restore general operations and improve patient access to care, questions surrounding transplant services may continue to affect public confidence.

Health experts warn that rebuilding trust will require transparency, strong regulatory enforcement, and clear communication with the public. The Ministry of Health has been urged to strengthen monitoring mechanisms, particularly in areas involving organ transplants, to prevent any recurrence of alleged malpractice.

The case has also drawn international attention, placing Kenya’s healthcare governance under scrutiny. Observers note that how authorities handle the situation moving forward could have implications for the country’s global reputation in medical ethics and oversight.

As Mediheal prepares to resume normal operations, stakeholders across the health sector face the challenge of balancing service delivery with accountability. The committee’s recommendation may offer institutional relief, but the continued suspension of transplant licenses underscores the need for caution and sustained investigation.

For now, patients are expected to benefit from the restoration of non-transplant services, even as the broader questions surrounding the allegations remain unresolved.